Xtant Medical to Announce Second Quarter 2025 Financial Results on August 12, 2025

Rhea-AI Summary

Xtant Medical Holdings (NYSE American: XTNT), a global medical technology company specializing in surgical solutions for spinal, orthopedic, and woundcare disorders, has scheduled its second quarter 2025 financial results announcement for August 12, 2025, before market open.

The company will host a conference call at 8:30 AM ET on the same day, featuring President and CEO Sean Browne and CFO Scott Neils. Investors can access the call through domestic (877-545-0523) and international (973-528-0016) dial-in numbers using passcode 482755. A webcast will be available, with a replay accessible on the company's website after the live call.

News Market Reaction – XTNT

-0.27%

1 alert

-0.27% News Effect

On the day this news was published, XTNT declined 0.27%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

BELGRADE, Mont., Aug. 5, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and woundcare disorders, today announced that it will release its financial results for the second quarter ended June 30, 2025, before the start of trading on Tuesday, August 12, 2025.

Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial officer, will host a conference call at 8:30am ET on that day.

Conference Details:

Conference Date: Tuesday, August 12, 2025

Conference Time: 8:30 AM ET

ConferenceDial-in: 877-545-0523

International Dial-in: 973-528-0016

Passcode: 482755

Conference Call Name: Xtant Medical Q2 2025 Financial Results

Webcast link: https://www.webcaster4.com/Webcast/Page/3039/52698

Following the live call, a replay will be available on the Company's website, https://xtantmedical.com/, under "Investor info."

About Xtant Medical Holdings, Inc.

Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics serving the chronic and surgical wound care and sports medicine markets, as well as spinal implant systems. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

View original content to download multimedia:https://www.prnewswire.com/news-releases/xtant-medical-to-announce-second-quarter-2025-financial-results-on-august-12-2025-302521141.html

SOURCE Xtant Medical Holdings, Inc.

FAQ

When will Xtant Medical (XTNT) release Q2 2025 earnings?

Xtant Medical will release Q2 2025 earnings on Tuesday, August 12, 2025, before the market opens.

How can investors access Xtant Medical's Q2 2025 earnings call?

Investors can join via phone (877-545-0523 US, 973-528-0016 International) with passcode 482755, or through the webcast at 8:30 AM ET on August 12, 2025.

Who will present during Xtant Medical's Q2 2025 earnings call?

Sean Browne (President and CEO) and Scott Neils (CFO) will host the conference call.

Where can I find the replay of Xtant Medical's Q2 2025 earnings call?

A replay will be available on Xtant Medical's website (https://xtantmedical.com/) under the 'Investor info' section after the live call.